Lubrizol LifeSciences adds new compounding capabilities

The Lubrizol Corporation’s LifeSciences (LLS) business has added compounding capabilities for its Pellethane and Isoplast products for medical device customers. This new offering enables Lubrizol Corporation, a Berkshire Hathaway company, to provide colour matching, radiopacity and custom compound development services and complements lifesciences’ existing polymer portfolio, formulation and manufacturing capabilities to enable success for medical device customers. 

This new capability is made possible through a partnership with custom medical plastics compounder, Compounding Solutions, who has committed to manufacture specialty plastics compounds & concentrates of high quality in order to satisfy requirements of the medical device industry.  

As part of this new service, LLS provides custom colour matching for brand recognition, safe identification and aesthetics in medical device applications. Since pigment requirements are ever changing, LLS pays close attention to ensure that colorants meet applicable regulatory requirements.